Literature DB >> 31584126

Potential role of IL-37 signaling pathway in feedback regulation of autoimmune Hashimoto thyroiditis.

Cui-Ping Ren1, Li Sun2, Feng-Chun Liu1, Chun-Lin Zuo2, Miao Liu1, Wenda Gao3, Ji-Jia Shen4.   

Abstract

IL-37, the anti-inflammatory cytokine of the IL-1 family, plays several key roles in the regulation of autoimmune diseases. Yet, its role in Hashimoto's thyroiditis (HT) is not clear. In the present study, we found that, in tissues from HT patients, most of the follicular epithelial cells were positive for both IL-37 and single Ig IL-1-related receptor (SIGIRR) by immunohistochemical staining, while the infiltrating lymphocytes and other inflammatory cells hardly expressed any. Meanwhile, mRNA expression levels of IL-37 in peripheral blood mononuclear cells (PBMC) of HT patients were significantly higher than those in normal controls measured by quantitative real-time PCR. Finally, we studied the possible role of IL-37 in IFN-γ-stimulated rat FRTL-5 cells. The results showed that IL-1β, TNF-α, and MCP-1 mRNA levels were significantly decreased, while the expression of IL-4 mRNA was dramatically up-regulated in IFN-γ-stimulated rat thyroid cell line FRTL-5 pre-treated with IL-37. The current study, for the first time, demonstrated that the IL-37 network is involved in Hashimoto's thyroiditis, and IL-37 signaling pathway may ameliorate the excessive autoimmune responses in this chronic lymphocytic thyroiditis.

Entities:  

Keywords:  Chronic lymphocytic thyroiditis; Hashimoto’s thyroiditis; IL-37; SIGIRR

Year:  2019        PMID: 31584126     DOI: 10.1007/s00418-019-01820-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  25 in total

1.  Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.

Authors:  R M Ruggeri; M Cristani; T M Vicchio; A Alibrandi; S Giovinazzo; A Saija; A Campennì; F Trimarchi; S Gangemi
Journal:  J Endocrinol Invest       Date:  2018-05-23       Impact factor: 4.256

2.  IL-37: a new player in immune tolerance.

Authors:  Hui-min Chen; Mayumi Fujita
Journal:  Cytokine       Date:  2015-01-12       Impact factor: 3.861

3.  IL-37 protects against obesity-induced inflammation and insulin resistance.

Authors:  Dov B Ballak; Janna A van Diepen; Alexander R Moschen; Henry J Jansen; Anneke Hijmans; Gert-Jan Groenhof; Floris Leenders; Philip Bufler; Mark V Boekschoten; Michael Müller; Sander Kersten; Suzhao Li; SooHyun Kim; Hadar Eini; Eli C Lewis; Leo A B Joosten; Herbert Tilg; Mihai G Netea; Cees J Tack; Charles A Dinarello; Rinke Stienstra
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

Review 4.  Hashimoto thyroiditis: clinical and diagnostic criteria.

Authors:  P Caturegli; A De Remigis; N R Rose
Journal:  Autoimmun Rev       Date:  2014-01-13       Impact factor: 9.754

5.  Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis.

Authors:  Libin Yang; Jun Zhang; Jingang Tao; Tan Lu
Journal:  APMIS       Date:  2015-12       Impact factor: 3.205

Review 6.  Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?

Authors:  Margret Ehlers; Matthias Schott
Journal:  Trends Endocrinol Metab       Date:  2014-10-09       Impact factor: 12.015

7.  IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.

Authors:  Claudia A Nold-Petry; Camden Y Lo; Ina Rudloff; Kirstin D Elgass; Suzhao Li; Michael P Gantier; Amelie S Lotz-Havla; Søren W Gersting; Steven X Cho; Jason C Lao; Andrew M Ellisdon; Björn Rotter; Tania Azam; Niamh E Mangan; Fernando J Rossello; James C Whisstock; Philip Bufler; Cecilia Garlanda; Alberto Mantovani; Charles A Dinarello; Marcel F Nold
Journal:  Nat Immunol       Date:  2015-03-02       Impact factor: 31.250

8.  Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome.

Authors:  Cong Li; Pingwei Zhao; Xiguang Sun; Yuanyuan Che; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2013-09-19       Impact factor: 4.711

9.  TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity.

Authors:  Federica Riva; Eduardo Bonavita; Elisa Barbati; Marta Muzio; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2012-10-29       Impact factor: 7.561

10.  Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.

Authors:  Qingwei Ji; Qiutang Zeng; Ying Huang; Ying Shi; Yingzhong Lin; Zhengde Lu; Kai Meng; Bangwei Wu; Kunwu Yu; Meng Chai; Yuyang Liu; Yujie Zhou
Journal:  Mediators Inflamm       Date:  2014-03-06       Impact factor: 4.711

View more
  1 in total

Review 1.  Current Understanding of IL-37 in Human Health and Disease.

Authors:  Zhangci Su; Xiaoan Tao
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.